Limei Cheng

Limei Cheng, PhD, currently serves as the Senior Director and Quantitative Systems Pharmacology (QSP) Lead/PMx at Incyte, a position held since July 2023. Prior experience includes a tenure at Bristol Myers Squibb from September 2015 to July 2023, where Limei led QSP development for cardiovascular diseases, focusing on heart failure and thrombosis, while also managing cross-functional teams and delivering high-quality outcomes. Additional roles at Bristol Myers Squibb involved developing pharmacokinetics and exposure-response models for oncology projects, mentoring junior scientists, and collaborating with multidisciplinary teams. Earlier, Limei held positions at Philips Research North America as a Research Scientist and at the University of Southern California as a Postdoctoral Research Associate and Graduate Research Assistant, emphasizing advanced research in medical technologies and physiological systems. Limei holds a PhD in Biomedical Engineering from the University of Southern California, an MSc in Electrical Engineering from UCLA, and a Bachelor’s degree in Biomedical Electronics Engineering and Instrumentation from Xi'an Jiaotong University.